Burden and clinical impact of chemotherapy-induced adverse drug reactions: A prospective observational study abstract

< 0.0001). Medication adherence declined with increasing age, with no patients aged ≥80 years demonstrating high adherence.ConclusionChemotherapy-induced ADRs represent a significant clinical and economic burden. Strengthened pharmacovigilance, individualized treatment strategies, and cost-effective interventions are essential to improve patient safety and optimize oncology care outcomes